Author: Nas, Kemal; Eryilmaz, Nuran; Geyik, Mehmet Faruk; AltaÅŸ, Ayfer
Title: COVID-19 in patients with familial Mediterranean fever treated with colchicine: case based review Cord-id: 7r37zjep Document date: 2021_2_21
ID: 7r37zjep
Snippet: Coronavirus disease 2019 (COVID-19) refers to the clinical picture of an important and severe infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering the current knowledge on the pathophysiology and clinical manifestations of COVID-19, it is safe to state that both COVID-19 and inflammatory rheumatic disorders cause a cytokine storm and merit treatment with anti-rheumatic drugs. Three patients, who were on regular follow-up due to the diagnosis of f
Document: Coronavirus disease 2019 (COVID-19) refers to the clinical picture of an important and severe infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering the current knowledge on the pathophysiology and clinical manifestations of COVID-19, it is safe to state that both COVID-19 and inflammatory rheumatic disorders cause a cytokine storm and merit treatment with anti-rheumatic drugs. Three patients, who were on regular follow-up due to the diagnosis of familial Mediterranean fever (FMF), contracted COVID-19 infection; and their pre-clinical and post-clinical data as well as laboratory, prognosis and treatment data were investigated. Effects of colchicine in FMF patients who contracted COVID-19 infection were presented in this study. All the cases recovered from COVID-19 without complications. The present study suggests that colchicine can positively affect the prognosis of COVID-19 in FMF patients; therefore, experience of rheumatologists in the use of anti-inflammatory drugs can be highly instrumental in management of COVID-19 patients.
Search related documents:
Co phrase search for related documents- abdominal pain and additional disease: 1
- abdominal pain and additional risk: 1, 2, 3, 4
- abdominal pain and additional symptom: 1, 2
- abdominal pain and loading dose: 1, 2
- abdominal pain and long term efficacy: 1
- abdominal pain and long term therapy: 1, 2, 3, 4
- actin cytoskeleton and acute ards respiratory distress syndrome: 1
- acute ards respiratory distress syndrome and additional disease: 1
- acute ards respiratory distress syndrome and additional risk: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and administer therapy: 1, 2
- acute ards respiratory distress syndrome and loading dose: 1
- acute ards respiratory distress syndrome and long term therapy: 1
- acute lung injury and additional risk: 1
- acute lung injury and administer therapy: 1
- acute lung injury and long term therapy: 1
- additional disease and long term therapy: 1
- additional risk and long term therapy: 1
Co phrase search for related documents, hyperlinks ordered by date